Cepharanthine, A Regulator Of Keap1-Nrf2, Inhibits Gastric Cancer Growth Through Oxidative Stress And Energy Metabolism Pathway
December 2023
in “
Cell Death Discovery
”
Studysummary This study found that cepharanthine can inhibit gastric cancer cell activity by inducing oxidative stress and altering energy metabolism, suggesting its potential for gastric cancer treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on nature.com →